EQNR vs. NVS
EQNR (Equinor ASA) and NVS (Novartis AG) are both stocks. EQNR operates in Oil & Gas Integrated (Energy), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, EQNR returned 23.33%/yr vs 14.91%/yr for NVS. Their 0.16 correlation means their historical movements had little consistent relationship.
Performance
EQNR vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EQNR achieves a 69.69% return, which is significantly higher than NVS's 14.55% return.
EQNR
- 1D
- -1.85%
- 1M
- 22.25%
- 6M
- 52.24%
- YTD
- 69.69%
- 1Y
- 63.93%
- 3Y*
- 18.33%
- 5Y*
- 23.33%
- 10Y*
- —
- ALL TIME*
- 11.15%
NVS
- 1D
- -0.26%
- 1M
- -4.15%
- 6M
- 5.39%
- YTD
- 14.55%
- 1Y
- 34.04%
- 3Y*
- 18.64%
- 5Y*
- 14.91%
- 10Y*
- 10.27%
- ALL TIME*
- 9.02%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
EQNR Equinor ASA | $164.63M | $152.52M | $142.52M |
NVS Novartis AG | $270.65M | $275.41M | $281.00M |
EQNR vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
EQNR Equinor ASA | 69.69% | 7.70% | -15.98% | -0.78% | 40.77% | 64.55% | -13.57% | -0.99% | -21.06% |
NVS Novartis AG | 14.55% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 10.79% |
Correlation
The correlation between EQNR and NVS is -0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.08 |
Correlation (3Y) Balances recent behavior with more history. | 0.06 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (All Time) Calculated using the full available price history since May 16, 2018 | 0.16 |
The correlation between EQNR and NVS shifts across timeframes, from -0.08 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.
Fundamentals
EQNR:
$93.65B
NVS:
$291.32B
EQNR:
$3.59
NVS:
$6.63
EQNR:
10.91
NVS:
23.12
EQNR:
0.34
NVS:
1.56
EQNR:
0.87
NVS:
5.30
EQNR:
2.22
NVS:
7.06
EQNR:
$113.62B
NVS:
$55.63B
EQNR:
$43.36B
NVS:
$41.41B
EQNR:
$46.11B
NVS:
$22.26B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EQNR vs. NVS — Risk / Return Rank
EQNR
NVS
EQNR vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Equinor ASA (EQNR) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EQNR | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.11 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.28 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.46 | 2.70 | -0.24 |
| Martin ratioReturn relative to average drawdown | 7.17 | 6.32 | +0.86 |
Loading charts...
Drawdowns
EQNR vs. NVS - Drawdown Comparison
The maximum EQNR drawdown since its inception was -66.77%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for EQNR and NVS.
Loading charts...
Drawdown Indicators
| EQNR | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.77% | -42.10% | -24.67% |
Max Drawdown (1Y)Largest decline over 1 year | -26.07% | -12.65% | -13.42% |
Max Drawdown (3Y)Largest decline over 3 years | -27.58% | -19.95% | -7.63% |
Max Drawdown (5Y)Largest decline over 5 years | -35.50% | -20.42% | -15.08% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.03% | — |
Current DrawdownCurrent decline from peak | -6.67% | -6.34% | -0.33% |
Average DrawdownAverage peak-to-trough decline | -21.36% | -10.90% | -10.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.94% | 5.40% | +3.54% |
Volatility
EQNR vs. NVS - Volatility Comparison
Equinor ASA (EQNR) has a higher volatility of 14.65% compared to Novartis AG (NVS) at 6.53%. This indicates that EQNR's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EQNR | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.65% | 6.53% | +8.12% |
Volatility (6M)Calculated over the trailing 6-month period | 32.32% | 16.07% | +16.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.90% | 21.62% | +16.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.32% | 19.29% | +15.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 36.45% | 19.74% | +16.71% |
Dividends
EQNR vs. NVS - Dividend Comparison
EQNR's dividend yield for the trailing twelve months is around 3.83%, more than NVS's 3.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EQNR Equinor ASA | 3.83% | 7.66% | 12.66% | 11.38% | 3.30% | 2.13% | 4.32% | 5.07% | 3.26% | 0.00% | 0.00% | 0.00% |
NVS Novartis AG | 3.11% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
EQNR vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Equinor ASA and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EQNR vs. NVS - Profitability Comparison
EQNR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Equinor ASA reported a gross profit of 15.87B and revenue of 34.52B. Therefore, the gross margin over that period was 46.0%.
NVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a gross profit of 10.74B and revenue of 14.42B. Therefore, the gross margin over that period was 74.5%.
EQNR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Equinor ASA reported an operating income of 12.86B and revenue of 34.52B, resulting in an operating margin of 37.3%.
NVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported an operating income of 4.74B and revenue of 14.42B, resulting in an operating margin of 32.8%.
EQNR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Equinor ASA reported a net income of 4.85B and revenue of 34.52B, resulting in a net margin of 14.0%.
NVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novartis AG reported a net income of 3.27B and revenue of 14.42B, resulting in a net margin of 22.7%.
Frequently Asked Questions
EQNR and NVS have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EQNR has higher volatility (14.65%) compared to NVS (6.53%). In terms of maximum drawdown, EQNR dropped -66.77% vs NVS's -42.10%.
EQNR currently has the higher Sharpe Ratio (1.70 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EQNR and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer